Cytochrome P450 2C19 polymorphism, suboptimal reperfusion and all-cause mortality in patients with acute myocardial infarction

被引：0
|
作者：
Malek, L. A. [1 ]
Klopotowski, M. [1 ]
Kostrzewa, G. [2 ]
Spiewak, M. [1 ]
Przyluski, J. [1 ]
Witkowski, A. [1 ]
机构：
[1] Natl Inst Cardiol, Warsaw, Poland
[2] Med Univ Warsaw, Warsaw, Poland
来源：
EUROPEAN HEART JOURNAL | 2010年 / 31卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：496 / 497
页数：2
相关论文
共 50 条
  • [1] Cytochrome P450 2C19 Polymorphism, Suboptimal Reperfusion and All-Cause Mortality in Patients with Acute Myocardial Infarction
    Malek, Lukasz A.
    Przyluski, Jakub
    Spiewak, Mateusz
    Klopotowski, Mariusz
    Kostrzewa, Grazyna
    Kruk, Mariusz
    Ploski, Rafal
    Witkowski, Adam
    Ruzyllo, Witold
    CARDIOLOGY, 2010, 117 (02) : 81 - 87
  • [2] Cytochrome P450 2C19 Polymorphism in Young Post-Myocardial Infarction Patients Treated With Clopidogrel
    Collet, Jean-Philippe
    Hulot, Jean-Sebastien
    Pena, Ana
    Villard, Eric
    Esteve, Jean-Baptiste
    Silvain, Johanne
    Payot, Laurent
    Cayla, Guillaume
    Beygui, Farzin
    Brugier, Delphine
    Funck-Brentano, Christian
    Montalescot, Gilles
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 53 (10) : A344 - A344
  • [3] Cigarette smoking might weaken the prognostic significance of cytochrome P450 2C19*2 polymorphism in acute myocardial infarction patients
    Zhang, Mingyu
    Liu, Xiaoxia
    Wang, Lei
    Wang, Yan
    Ju, Li
    Li, Jianfei
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2016, 20 (07) : 1247 - 1254
  • [4] Impact of the cytochrome P450 2C19*3 polymorphism on platelet reactivity and adverse clinical events in patients with acute myocardial infarction
    Jeong, Y. H.
    Tantry, U. T.
    Jung, T. J.
    Park, Y. H.
    Kim, I. S.
    Bliden, K. A.
    Gurbel, P. A.
    EUROPEAN HEART JOURNAL, 2011, 32 : 508 - 508
  • [5] Impact of the cytochrome P450 2C19*3 polymorphism on platelet reactivity and adverse clinical events in patients with acute myocardial infarction
    Jeong, Y-H
    Koh, J-S
    Kwon, T. J.
    Park, Y.
    Kim, I-S
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 793 - 793
  • [6] Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study
    Collet, Jean-Philippe
    Hulot, Jean-Sebastien
    Pena, Anna
    Villard, Eric
    Esteve, Jean-Baptiste
    Silvain, Johanne
    Payot, Laurent
    Brugier, Delphine
    Cayla, Guillaume
    Beygui, Farzin
    Bensimon, Gilbert
    Funck-Brentano, Christian
    Montalescot, Gilles
    LANCET, 2009, 373 (9660): : 309 - 317
  • [7] GENETIC POLYMORPHISM OF CYTOCHROME P450 (2C19) IN PATIENTS WITH RENAL TRANSPLANT
    Ciftci, Hayriye Senturk
    Tefik, Tzevat
    Turkmen, Aydin
    Nane, Ismet
    Oguz, Fatma Savran
    Aydin, Filiz
    TISSUE ANTIGENS, 2014, 84 (01): : 58 - 59
  • [8] Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: impact on clinical events and on
    Collet, J. -P.
    Hulot, J. S.
    Pena, A. N. A.
    Vilard, E. R. I. C.
    Esteve, J. B.
    Cayla, G.
    Silvain, G.
    Beygui, F.
    Payot, L.
    Montalescot, G.
    EUROPEAN HEART JOURNAL, 2009, 30 : 906 - 906
  • [9] Cytochrome P450 2C19 polymorphism and clopidogrel after MI
    Bhattacharyya, Sanjeev
    Rakhit, Roby
    LANCET, 2009, 373 (9670): : 1171 - 1171
  • [10] Clinical Significance of the Cytochrome P450 2C19 Genetic Polymorphism
    Zeruesenay Desta
    Xiaojiong Zhao
    Jae-Gook Shin
    David A. Flockhart
    Clinical Pharmacokinetics, 2002, 41 : 913 - 958
12345